Clover Health Investments, Corp. (NASDAQ:CLOV – Get Free Report) traded up 4% on Monday . The company traded as high as $4.24 and last traded at $4.16. 1,550,396 shares were traded during trading, a decline of 81% from the average session volume of 8,079,142 shares. The stock had previously closed at $4.00.
Wall Street Analysts Forecast Growth
Separately, UBS Group began coverage on shares of Clover Health Investments in a research report on Monday, October 7th. They issued a “neutral” rating and a $4.00 price objective for the company.
View Our Latest Stock Analysis on CLOV
Clover Health Investments Trading Up 1.3 %
Clover Health Investments (NASDAQ:CLOV – Get Free Report) last released its quarterly earnings results on Monday, August 5th. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.05. Clover Health Investments had a negative net margin of 7.30% and a negative return on equity of 36.55%. The company had revenue of $356.26 million during the quarter, compared to analysts’ expectations of $338.70 million. During the same quarter in the prior year, the company earned ($0.06) earnings per share. As a group, sell-side analysts expect that Clover Health Investments, Corp. will post -0.13 EPS for the current year.
Institutional Trading of Clover Health Investments
A number of institutional investors have recently modified their holdings of CLOV. Allspring Global Investments Holdings LLC increased its position in shares of Clover Health Investments by 151.2% in the first quarter. Allspring Global Investments Holdings LLC now owns 77,948 shares of the company’s stock valued at $62,000 after acquiring an additional 46,912 shares during the last quarter. Jupiter Asset Management Ltd. grew its holdings in Clover Health Investments by 18.1% during the first quarter. Jupiter Asset Management Ltd. now owns 4,525,079 shares of the company’s stock worth $3,593,000 after purchasing an additional 692,878 shares during the period. Bayesian Capital Management LP acquired a new position in Clover Health Investments during the first quarter worth approximately $142,000. Jacobs Levy Equity Management Inc. acquired a new stake in shares of Clover Health Investments in the first quarter valued at approximately $91,000. Finally, Jaffetilchin Investment Partners LLC boosted its stake in shares of Clover Health Investments by 30.2% during the 1st quarter. Jaffetilchin Investment Partners LLC now owns 49,741 shares of the company’s stock worth $39,000 after acquiring an additional 11,550 shares during the period. 19.77% of the stock is currently owned by institutional investors.
Clover Health Investments Company Profile
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.
Further Reading
- Five stocks we like better than Clover Health Investments
- How to Invest in Blue Chip Stocks
- Analysts Predict New Highs for Cybersecurity Stock by Christmas
- What is the Australian Securities Exchange (ASX)
- Nuclear Power Reaches Critical Mass: Top Stocks to Watch Now
- 3 Best Fintech Stocks for a Portfolio Boost
- 2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments
Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.